Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement.

Autor: Nabki J; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Al Deeban B; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Sium AM; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Cosentino C; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Almasri M; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Awikeh B; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Maher N; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Bellia M; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Dondolin R; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Mouhssine S; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Talotta D; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Secomandi E; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Kogila S; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Ghanej J; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Maiellaro F; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Cividini L; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Rasi S; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Chiarenza A; Division of Haematology, Ferrarotto Hospital, Catania, Italy., Olivieri J; Clinica Ematologica, Centro Trapianti e Terapie Cellulari 'Carlo Melzi' DISM, Azienda Ospedaliera Universitaria S. Maria Misericordia, Udine, Italy., Gentile M; Hematology Unit AO of Cosenza, Cosenza, Italy.; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy., Zaja F; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy., Del Principe MI; Hematology, Department of Biomedicine and Prevention, Tor Vergata University of Rome, Rome, Italy., Laurenti L; Dipartimento di Science di Laboratorio ed Ematologiche, Area di Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore-Roma, Rome, Italy., Bomben R; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Vit F; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Bittolo T; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Zucchetto A; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Gattei V; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Gaidano G; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Moia R; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy. riccardo.moia@uniupo.it.

Publikováno v: Leukemia [Leukemia] 2024 Dec 17. Date of Electronic Publication: 2024 Dec 17.

PRIMARY PREVENTION OF DIABETES: What Can Be Done and How Much Can Be Prevented?

Autor: Schulze, Matthias B.¹ mschulze@mail.dife.de, Hu, Frank B.^1,2,3 frank.hu@channing.harvard.edu

Publikováno v: Annual Review of Public Health. 2005, Vol. 26 Issue 1, p445-467. 23p. 1 Chart, 2 Graphs.

Fatigue and Fracture Characterization of HPDC AM6OB Magnesium Alloy at Cold Temperature.

Autor: Nur Hossain, Md., Taheri, Farid

Publikováno v: Journal of Materials Engineering & Performance; Dec2011, Vol. 20 Issue 9, p1684-1689, 6p

Transcription profiling of HCN-channel isotypes throughout mouse cardiac development.

Autor: Schweizer, Patrick A., Yampolsky, Pessah, Malik, Rizwan, Thomas, Dierk, Zehelein, Joerg, Katus, Hugo A., Koenen, Michael

Publikováno v: Basic Research in Cardiology; Nov2009, Vol. 104 Issue 6, p621-629, 9p, 5 Graphs

Deutscher Brückenbaupreis 2008 und 18. Dresdner Brückenbausymposium.

Autor: Stritzke, Jürgen

Publikováno v: Bautechnik; Jul2008, Vol. 85 Issue 7, p484-492, 9p